ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Kolchinsky Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Wave Life Sciences Ltd. (Director · Since at least Aug 14, 2015); Black Diamond Therapeutics, Inc. (Director · Jul 5, 2023 – Jul 5, 2023 · Past); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Research Alliance Corp II (Chief Executive Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Solid Biosciences Inc. (Director · Dec 10, 2020 – Jan 11, 2024 · Past); POINT Biopharma Global Inc (Chief Executive Officer, Director · Jul 7, 2020 – Jun 29, 2021 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Jun 8, 2022 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 3, 2022 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Kala Bio, Inc. (Director · Oct 3, 2018 – Mar 13, 2020 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jun 19, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Jun 20, 2017 – Apr 2, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 27, 2019 · Past) | Director · Since at least Nov 8, 2022 |
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Since at least Nov 8, 2022 |
| James Flynn Other companies: Lite Strategy, Inc. (Non-Executive Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); Oruka Therapeutics, Inc. (Director · Dec 15, 2022 – Jan 30, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past) | Director · Nov 8, 2022 – Nov 8, 2022 · Past |
| Peter Thompson Other companies: Aspen Neuroscience, Inc. (General Partner · Since at least Nov 2, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Edgewise Therapeutics, Inc. (Chairman and Co-Founder · Since at least Mar 25, 2021); Corvus Pharmaceuticals, Inc. (CO-FOUNDER · Since at least Mar 22, 2016); Janux Therapeutics, Inc. (Director · Jun 10, 2021 – Jun 14, 2022 · Past); Decibel Therapeutics Inc (Director · Feb 11, 2021 – Jun 17, 2022 · Past); PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Jun 2, 2021 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 13, 2018 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jun 4, 2018 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Anthera Pharmaceuticals Inc (Director · Feb 1, 2011 – May 8, 2012 · Past); Trubion Pharmaceuticals Inc (President and CEO, Director · Oct 17, 2006 – Aug 27, 2009 · Past) | Director · Since at least Dec 3, 2020 |
| Vickie Capps Other companies: Orthofix Medical Inc. (Director · Since at least Mar 11, 2025); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Amedisys Inc (Director · Since at least Nov 1, 2019); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); NuVasive Inc (Director · Jun 12, 2015 – Sep 1, 2023 · Past); Connecture Inc (Director · Dec 11, 2014 – Apr 25, 2018 · Past); Otonomy Inc (Director · Aug 12, 2014 – Nov 28, 2022 · Past); Senorx Inc (Director · Jun 14, 2007 – Feb 26, 2010 · Past); Djo Inc (Executive VP, CFO · Jun 28, 2006 – Nov 20, 2007 · Past) | Director · Dec 3, 2020 – Jun 10, 2022 · Past |
| Robert Hershberg Other companies: Danaher Corporation (Director · Since at least Nov 15, 2026); AtaiBeckley Inc. (Director · Since at least Jun 4, 2026); Hillevax Inc (President and CEO, Director · Since at least Apr 28, 2022); Recursion Pharmaceuticals, Inc. (Board Member · Since at least Apr 15, 2021); Adaptive Biotechnologies Corporation (Board Member · Since at least Jun 26, 2019); Fate Therapeutics, Inc. (Director · May 1, 2020 – Jun 6, 2023 · Past); NanoString Technologies Inc (Director · Mar 2, 2015 – Apr 18, 2022 · Past); Dendreon Corp (Sr. VP & Chief Medical Officer · Dec 31, 2005 – Jan 19, 2006 · Past) | Director · Dec 3, 2020 – Jun 10, 2022 · Past |
| Brent Saunders Other companies: Bausch + Lomb Corporation (Chairman of the Board and CEO, Director · Since at least Mar 6, 2023); SkinHealth Systems Inc. (Chairman · Since at least Sep 29, 2020); BridgeBio Pharma, Inc. (Director · Jun 23, 2020 – Jun 22, 2022 · Past); Cisco Systems, Inc. (Director · Mar 13, 2017 – Dec 8, 2022 · Past); Forest Laboratories Inc (CEO & President, Director · Aug 23, 2011 – Jun 30, 2014 · Past); Merck & Company, Inc. (Senior Vice President · May 19, 2006 – Nov 3, 2009 · Past) | Director · Since at least Nov 8, 2022 |
| Jonathan Leff Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Alpine Immune Sciences Inc (Director · Jun 16, 2015 – Sep 11, 2015 · Past); InterMune Inc (EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past) | Director · Nov 8, 2022 – Nov 8, 2022 · Past |
| Jonathan Root Other companies: Carlsmed, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jul 22, 2025); Omada Health, Inc. (Director · Since at least Jun 5, 2025); Edgewise Therapeutics, Inc. (Director · Since at least Mar 25, 2021); eFFECTOR Therapeutics Inc (Director · Aug 25, 2021 – Dec 2, 2021 · Past); Inari Medical Inc (Director · May 21, 2020 – Feb 19, 2025 · Past); OncoMed Pharmaceuticals Inc (Director · Jul 17, 2013 – Apr 23, 2019 · Past) | Director · Dec 3, 2020 – Jun 10, 2022 · Past |
| Phillip Schneider Other companies: Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); Pfenex Inc (Director · Jul 24, 2014 – Oct 1, 2020 · Past); Auspex Pharmaceuticals Inc (Director · Feb 4, 2014 – May 5, 2015 · Past); Arena Pharmaceuticals Inc (Director · Dec 11, 2007 – Jun 13, 2017 · Past) | Director · Since at least Nov 8, 2022 |
| Alexander Fitzpatrick Other companies: Evofem Biosciences, Inc. (General Counsel and Secretary · Jan 17, 2018 – Feb 18, 2022 · Past); Verenium Corp (Sr. VP & General Counsel · Nov 8, 2010 – Oct 31, 2013 · Past); Kintera Inc (SVP and General Counsel · May 2, 2007 – Jul 8, 2008 · Past) | Chief Legal Officer · Since at least Dec 1, 2022 |
| Andrew Kenneth William Powell Other companies: Synthorx Inc (Director · Dec 19, 2018 – Jan 23, 2020 · Past); Lifecore Biomedical, Inc. (Director · Oct 12, 2018 – Jun 4, 2022 · Past); Aclaris Therapeutics, Inc. (Director · May 16, 2018 – Jun 1, 2024 · Past) | Director · Dec 3, 2020 – Jun 10, 2022 · Past |
| Brian T. Dorsey Other companies: Apricus Biosciences Inc (SVP, Chief Development Officer · Dec 1, 2014 – Jan 1, 2018 · Past); Pernix Therapeutics Holdings Inc (SVP Research · Apr 19, 2013 – Oct 10, 2014 · Past); Somaxon Pharmaceuticals Inc (SVP, Technical Operations · Nov 9, 2006 – Dec 31, 2012 · Past) | Chief Operating Officer · Since at least Dec 6, 2022 |
| Kathleen Scott Other companies: Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021); NKGen Biotech Inc. (Director · Sep 29, 2023 – Dec 6, 2024 · Past); Histogen Inc (Director · Nov 18, 2019 – Nov 18, 2019 · Past) | Chief Financial Officer · Since at least Nov 8, 2022 |
| Laura Shawver Other companies: Relay Therapeutics, Inc. (Director · Jul 15, 2020 – Jun 3, 2024 · Past); Nkarta, Inc. (Director · Jul 9, 2020 – Jun 8, 2022 · Past); Synthorx Inc (President and CEO, Director · Dec 6, 2018 – Jan 23, 2020 · Past) | Director · Since at least Dec 3, 2020 |
| Randall Kaye Other companies: Longboard Pharmaceuticals Inc (Executive Vice President & CMO · Mar 21, 2022 – Dec 2, 2024 · Past); Axsome Therapeutics, Inc. (Chief Medical Officer · Nov 19, 2015 – Dec 23, 2015 · Past); Avanir Pharmaceuticals Inc (Sr. VP, Chief Medical Officer · Jan 16, 2006 – Sep 9, 2011 · Past) | Chief Medical Officer · Since at least Nov 5, 2026 |
| Thilo Schroeder Other companies: PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Oct 6, 2021 · Past); Revolution Medicines, Inc. (Director · Feb 12, 2020 – Dec 5, 2024 · Past); IDEAYA Biosciences, Inc. (Director · May 22, 2019 – May 22, 2019 · Past) | Director · Dec 3, 2020 – Dec 8, 2020 · Past |
| Maria Koehler Other companies: ImageneBio, Inc. (Director · Apr 15, 2021 – Jun 7, 2024 · Past); Repare Therapeutics Inc (EVP, CHIEF MEDICAL OFFICER · Jun 18, 2020 – Mar 12, 2025 · Past) | Director · Mar 12, 2021 – Jun 10, 2022 · Past |
| Pratik Shah Other companies: Design Therapeutics, Inc. (Co-Founder, President, CEO and Chairperson · Since at least Mar 25, 2021); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past) | Director and Chair of the Board · Since at least Nov 8, 2022 |
| Saqib Islam Other companies: Passage Bio, Inc. (Director · Since at least May 27, 2021); SpringWorks Therapeutics Inc (Chief Executive Officer, Director · Since at least Jan 7, 2021) | Director · Since at least Dec 3, 2020 |
| Michael Kelly Other companies: Hemab Therapeutics Holdings, Inc. (Vice President, Clinical Development · Since at least Nov 5, 2026) | Director · Since at least Nov 8, 2022 |
| Valerie Odegard Other companies: Odyssey Therapeutics, Inc. (Director · Since at least May 7, 2026) | President and CSO · Dec 3, 2020 – May 2, 2022 · Past |
| Brenton Saunders | Director · Since at least Nov 5, 2026 |
| Daniel Relovsky | Senior Vice President, Marketing · Since at least Nov 5, 2026 |
| Donn Casale | President, Chief Executive Officer and Director · Since at least Jun 1, 2026 |
| Eric Karas | Chief Commercial Officer · Since at least Nov 8, 2022 |
| Jeffrey C Pepe | Interim CEO and GC · Sep 2, 2022 – Sep 2, 2022 · Past |
| John Slebir | Chief Legal Officer · Since at least Nov 5, 2026 |
| Jonathan Piazza | Chief Financial Officer · Dec 3, 2020 – May 2, 2022 · Past |
| Justin Chakma | Chief Business Officer · Since at least Nov 8, 2022 |
| Lynda Harris | Vice President, Human Resources · Since at least Nov 5, 2026 |
| Margaret Ekins Smith | Chief Commercial Officer · Since at least Aug 17, 2026 |
| Meg Smith | Chief Commercial Officer · Since at least Aug 13, 2026 |
| Naomi Hunder | Chief Medical Officer · Dec 3, 2020 – May 2, 2022 · Past |
| Rajeev Dadoo | Director · Since at least Nov 8, 2022 |
| Richard Lowenthal | Director · Since at least Nov 8, 2022 |
| Russ Hawkinson | Sr. Vice President of Finance · Dec 3, 2020 – May 2, 2022 · Past |
| Sarina Tanimoto | CHIEF MEDICAL OFFICER · Since at least Nov 8, 2022 |